A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004 Meeting Abstract
| Authors: | Dawson, N. A.; Halabi, S.; Biggs, D. D.; Ou, S. S.; Kelly, W. K.; Small, E. J. |
| Abstract Title: | A phase II study of estramustine (E), docetaxel (D) and exisulind in hormonerefractory prostate cancer (HRPC): Initial results of CALGB 90004 |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 415S |
| Language: | English |
| ACCESSION: | WOS:000230326602478 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.4649 |
| Notes: | --- - Meeting Abstract: 4649 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos" |
